Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04791098

Impact of Infectious Diseases Consultation on Vaccination Coverage Among People Waiting for a Kidney Transplant at the Clermont-Ferrand Hospital

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Solid-organ transplant patients are at increased risk of infectious diseases. Among this population, infectious diseases may be life-threatening or lead to graft rejection. Their prevention is an important challenge. Despite specific national recommendations, vaccination is underutilized. That is why we propose a dedicated infectious diseases consultation during pre-kidney transplantation assessment.

Detailed description

The main objective of this study is to impove vaccine coverage before kidney transplantation. Enrollment was based on the waiting list for a kidney transplant. Patients newly listed are invited to participate by the transplant team (nephrology department) ; for those that are already registered, a notification letter is sent to their home. All patients included must : * complete a health questionnaire * take a blood test at day 0 : viral, bacterial and parasitic serologies, QuantiFERON-TB * take a chest X-ray and dental panoramic Patients randomized in interventional group will be seen in specific infectious diseases consultation at Clermont Ferrand Hospital. A letter of recommendations is sent to nephrologist for patients randomized in group control. The primary study endpoint (immunization coverage) is evaluated at 6 months.

Conditions

Interventions

TypeNameDescription
OTHERSpecific infectious diseases consultationSpecific infectious diseases consultation at Clermont Ferrand Hospital with a specialist doctor : * Update vaccinations * Advice to travelers * Diagnostic and treatment of latent tuberculosis infection

Timeline

Start date
2020-09-16
Primary completion
2022-03-01
Completion
2026-04-01
First posted
2021-03-10
Last updated
2021-03-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04791098. Inclusion in this directory is not an endorsement.